Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD

被引：16

作者：

Duchow, Ankelien ^{[1
,2
,3
,4
,5
]}

Bellmann-Strobl, Judith ^{[1
,2
,3
,4
,5
]}

Friede, Tim ^{[6
]}

Aktas, Orhan ^{[7
]}

Angstwurm, Klemens ^{[8
]}

Ayzenberg, Ilya ^{[9
]}

Berthele, Achim ^{[10
]}

Dawin, Eva ^{[11
]}

Engels, Daniel ^{[12
]}

Fischer, Katinka ^{[7
]}

Flaskamp, Martina ^{[10
]}

Giglhuber, Katrin ^{[10
]}

Grothe, Matthias ^{[13
]}

Havla, Joachim ^{[12
]}

Huemmert, Martin W. ^{[14
]}

Jarius, Sven ^{[15
]}

Kaste, Matthias ^{[16
]}

Kern, Peter ^{[17
]}

Kleiter, Ingo ^{[18
]}

Klotz, Luisa ^{[11
]}

Korporal-Kuhnke, Mirjam ^{[15
]}

Kraemer, Markus ^{[7
,19
]}

Krumbholz, Markus ^{[20
,21
,22
]}

Kuempfel, Tania ^{[12
]}

Lohmann, Lisa ^{[11
]}

Ringelstein, Marius ^{[7
,23
]}

Rommer, Paulus ^{[24
,25
]}

Schindler, Patrick ^{[1
,2
,3
,4
,5
]}

Schubert, Charlotte ^{[26
,27
,28
]}

Schwake, Carolin ^{[9
]}

Senel, Makbule ^{[29
]}

Then Bergh, Florian ^{[30
]}

Tkachenko, Daria ^{[14
]}

Tumani, Hayrettin ^{[29
]}

Trebst, Corinna ^{[14
]}

Vardakas, Ioannis ^{[29
]}

Walter, Annette ^{[31
]}

Warnke, Clemens ^{[32
,33
]}

Weber, Martin S. ^{[34
,35
]}

Wickel, Jonathan ^{[36
]}

Wildemann, Brigitte ^{[15
]}

Winkelmann, Alexander ^{[25
]}

Paul, Friedemann ^{[1
,2
,3
,4
,5
]}

Stellmann, Jan-Patrick ^{[26
,27
,28
,37
,38
]}

Haeussler, Vivien ^{[26
,27
,28
,39
,40
,41
]}

机构：

[1] Charite Univ Med Berlin, Neurosci Clin Res Ctr, Berlin, Germany

[2] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany

[3] Free Univ Berlin, Berlin, Germany

[4] Humboldt Univ, Berlin, Germany

[5] Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Berlin, Germany

[6] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany

[7] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Neurol, Dusseldorf, Germany

[8] Univ Regensburg, Dept Neurol, Regensburg, Germany

[9] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany

[10] Tech Univ Munich, Sch Med, Dept Neurol, Klinikum Rechts Isar, Munich, Germany

[11] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany

[12] Ludwig Maximilians Univ Munchen, LMU Hosp, Inst Clin Neuroimmunol, Munich, Germany

[13] Univ Greifswald, Dept Neurol, Greifswald, Germany

[14] Hannover Med Sch, Dept Neurol, Hannover, Germany

[15] Heidelberg Univ, Dept Neurol, Mol Neuroimmunol Grp, Heidelberg, Germany

[16] Nordwest Hosp Sanderbusch, Dept Neurol, Sande, Germany

[17] Asklepios Expert Clin Teupitz, Dept Neurol, Teupitz, Germany

[18] Behandlungszentrum Kempfenhausen Multiple Skleros, Marianne Strauss Klin, Berg, Germany

[19] Alfried Krupp Hosp, Dept Neurol, Essen, Germany

[20] Univ Hosp, Multiple Sclerosis Ctr, Ctr Translat Med, Dept Neurol & Pain Treatment,Brandenburg Med Sch, Rudersdorf, Germany

[21] Brandenburg Med Sch Theodor Fontane, Fac Hlth Sci Brandenburg, Rudersdorf, Germany

[22] Univ Hosp Tubingen, Dept Neurol & Stroke, Tubingen, Germany

[23] Heinrich Heine Univ Dusseldorf, Ctr Neurol & Neuropsychiat, Dept Neurol, LVR Klinikum, Dusseldorf, Germany

[24] Med Univ Vienna, Dept Neurol, Vienna, Austria

[25] Rostock Univ Med Ctr, Dept Neurol, Rostock, Germany

[26] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany

[27] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol, Hamburg, Germany

[28] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[29] Univ Ulm, Dept Neurol, Ulm, Germany

[30] Univ Leipzig, Dept Neurol, Leipzig, Germany

[31] Herford Hosp, Dept Neurol, Herford, Germany

[32] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany

[33] Univ Hosp Cologne, Gottingen, Germany

[34] Univ Med Ctr Gottingen, Inst Neuropathol, Dept Neurol, Gottingen, Germany

[35] Fraunhofer Inst Translat Med & Pharmacol, Jena, Germany

[36] Jena Univ Hosp, Dept Neurol, Sect Translat Neuroimmunol, Hamburg, Germany

[37] Hop La Timone, APHM, CEMEREM, Marseille, France

[38] Aix Marseille Univ, CNRS, CRMBM, Marseille, France

[39] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Eppendorf 52, D-20251 Hamburg, Germany

[40] Univ Med Ctr Hamburg Eppendorf, Eppendorf 52, D-20251 Hamburg, Germany

[41] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol, Eppendorf 52, D-20251 Hamburg, Germany

来源：

ANNALS OF NEUROLOGY | 2024年 / 95卷 / 04期

关键词：

OPTICA SPECTRUM DISORDER; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; MULTICENTER; IGG; PREDICTORS; EFFICACY; FEATURES;

D O I：

10.1002/ana.26858

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective: To investigate accumulation of disability in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) in a changing treatment landscape. We aimed to identify risk factors for the development of disability milestones in relation to disease duration, number of attacks, and age.Methods: We analyzed data from individuals with NMOSD and MOGAD from the German Neuromyelitis Optica Study Group registry. Applying survival analyses, we estimated risk factors and computed time to disability milestones as defined by the Expanded Disability Status Score (EDSS).Results: We included 483 patients: 298 AQP4-IgG(+) NMOSD, 52 AQP4-IgG(-)/MOG-IgG(-) NMOSD patients, and 133 patients with MOGAD. Despite comparable annualized attack rates, disability milestones occurred earlier and after less attacks in NMOSD patients than MOGAD patients (median time to EDSS 3: AQP4-IgG+ NMOSD 7.7 (95% CI 6.6-9.6) years, AQP4-IgG(-)/MOG-IgG(-) NMOSD 8.7) years, MOGAD 14.1 (95% CI 10.4-27.6) years; EDSS 4: 11.9 (95% CI 9.7-14.7), 11.6 (95% lower CI 7.6) and 20.4 (95% lower CI 14.1) years; EDSS 6: 20.1 (95% CI 16.5-32.1), 20.7 (95% lower CI 11.6), and 37.3 (95% lower CI 29.4) years; and EDSS 7: 34.2 (95% lower CI 31.1) for AQP4-IgG(+) NMOSD). Higher age at onset increased the risk for all disability milestones, while risk of disability decreased over time.Interpretation: AQP4-IgG(+) NMOSD, AQP4-IgG(-)/MOG-IgG(-) NMOSD, and MOGAD patients show distinctive relapse-associated disability progression, with MOGAD having a less severe disease course. Investigator-initiated research has led to increasing awareness and improved treatment strategies appearing to ameliorate disease outcomes for NMOSD and MOGAD.ANN NEUROL 2024

引用

页码：720 / 732

页数：13

共 50 条

[1] Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Juan I. Rojas
Agustín Pappolla
Liliana Patrucco
Edgardo Cristiano
Jimena Miguez
Susana Liwacki
Verónica Tkachuk
María E. Balbuena
Carlos Vrech
Norma Deri
Jorge Correale
Mariano Marrodan
María C. Ysrraelit
Marcela Fiol
Felisa Leguizamon
Geraldine Luetic
María L. Menichini
Pablo A. Lopez
Juan Pablo Pettinicchi
Juan Criniti
Alejandro Caride
Darío Tavolini
Carolina Mainella
Gisela Zanga
Marcos Burgos
Javier Hryb
Andrés Barboza
Luciana Lazaro
Ricardo Alonso
Berenice Silva
Nora Fernández Liguori
Débora Nadur
Aníbal Chercoff
Alejandra Martinez
Judith Steinberg
Orlando Garcea
Adriana Carrá
Marina Alonso Serena
Edgar Carnero Contentti
Neurological Sciences, 2023, 44 : 281 - 286
[2] Volumetric MRI in MOGAD and NMOSD compared to MS and healthy controls and association with disability
Kunchok, Amy
Cohen, Jeffrey
Bermel, Robert
Amin, Moein
Abbatemarco, Justin
Ontaneda, Daniel
Nakamura, Kunio
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 408 - 408
[3] Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Rojas, Juan, I
Pappolla, Agustin
Patrucco, Liliana
Cristiano, Edgardo
Miguez, Jimena
Liwacki, Susana
Tkachuk, Veronica
Balbuena, Maria E.
Vrech, Carlos
Deri, Norma
Correale, Jorge
Marrodan, Mariano
Ysrraelit, Maria C.
Fiol, Marcela
Leguizamon, Felisa
Luetic, Geraldine
Menichini, Maria L.
Lopez, Pablo A.
Pettinicchi, Juan Pablo
Criniti, Juan
Caride, Alejandro
Tavolini, Dario
Mainella, Carolina
Zanga, Gisela
Burgos, Marcos
Hryb, Javier
Barboza, Andres
Lazaro, Luciana
Alonso, Ricardo
Silva, Berenice
Liguori, Nora Fernandez
Nadur, Debora
Chercoff, Anibal
Martinez, Alejandra
Steinberg, Judith
Garcea, Orlando
Carra, Adriana
Serena, Marina Alonso
Contentti, Edgar Carnero
NEUROLOGICAL SCIENCES, 2023, 44 (01) : 281 - 286
[4] Prevalence of misdiagnosis and time to diagnosis amongst nmosd and mogad patients
Unsworth, Mia
Trenholm, Emily
Jones, Eddie
Grant, Nikisha
Lebrocq, Laura
Fitzmaurice, Kristie
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 652 - 652
[5] Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD
Chan, Fiona
Berhanu, David
Samadzadeh, Sara
Francis, Anna
Asgari, Nasrin
Paul, Friedemann
Leite, M. Isabel
Geraldes, Ruth
Palace, Jacqueline
MULTIPLE SCLEROSIS JOURNAL, 2025,
[6] Disability outcomes during follow-up in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Rojas, J. I.
Pappolla, A.
Patrucco, L.
Cristiano, E.
Miguez, J.
Liwacki, S.
Tkachuk, V.
Balbuena, M. E.
Vrech, C.
Deri, N.
Correale, J.
Marrodan, M.
Ysrraelit, M. C.
Negrotto, L.
Gaitan, M. I.
Fiol, M.
Leguizamon, F.
Luetic, G.
Menichini, M. L.
Lopez, P.
Pettinicchi, J. P.
Criniti, J.
Caride, A.
Tavolini, D.
Mainella, C.
Zanga, G.
Burgos, M.
Hryb, J.
Barboza, A.
Lazaro, L.
Alonso, R.
Silva, B.
Cohen, L.
Fernandez Liguori, N.
Nadur, D.
Chercoff, A.
Garcea, O.
Carra, A.
Alonso Serena, M.
Carnero Contentti, E.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 157 - 158
[7] Annualized relapse rates for a contemporary multiple sclerosis clinic in the UK: a retrospective cohort study
Hibbert, A.
Selvam, A. Panneer
Papathanasiou, A.
Evangelou, N.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 275 - 276
[8] Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
Dinoto, Alessandro
Sechi, Elia
Ferrari, Sergio
Gajofatto, Alberto
Orlandi, Riccardo
Solla, Paolo
Maccabeo, Alessandra
Maniscalco, Giorgia Teresa
Andreone, Vincenzo
Sartori, Arianna
Manganotti, Paolo
Rasia, Sarah
Capra, Ruggero
Mancinelli, Chiara Rosa
Mariotto, Sara
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
[9] Comparison of Relapse Rates and Treatment Failure Rates in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
Bilodeau, P. A.
Vishnevetsky, A.
Molazedeh, N.
Lotan, I.
Anderson, M.
Salky, R.
Romanow, G.
Chitnis, T.
Levy, M.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 164 - 165
[10] Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina
Contentti, Edgar Carnero
Lopez, Pablo A.
Pettinicchi, Juan Pablo
Criniti, Juan
Pappolla, Agustin
Miguez, Jimena
Patrucco, Liliana
Cristiano, Edgardo
Liwacki, Susana
Tkachuk, Veronica
Balbuena, Maria E.
Vrech, Carlos
Deri, Norma
Correale, Jorge
Marrodan, Mariano
Ysrraelit, Maria C.
Leguizamon, Felisa
Luetic, Geraldine
Menichini, Maria L.
Tavolini, Dario
Mainella, Carolina
Zanga, Gisela
Burgos, Marcos
Hryb, Javier
Barboza, Andres
Lazaro, Luciana
Alonso, Ricardo
Liguori, Nora Fernandez
Nadur, Debora
Chercoff, Anibal
Serena, Marina Alonso
Caride, Alejandro
Paul, Friedemann
Rojas, Juan, I
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (03)

← 1 2 3 4 5 →